It has been reported that endocytosis, endosome acidification, and endosome cathepsin proteases inhibitors attenuate infection mediated by the viral envelope glycoproteins of the Ebola or SARS-CoV-2 virus [3,4,5,6]. The gene discussed is ERVW-1; the disease is infection.